MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s)

Study summary

Does lung ablation improve clinical outcomes for patients deemed to be surgically high-risk?

Ask AI to explain this study

Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedMicrowave ablation

The study team can explain what participation involves.

Who it may be forMetastatic or stage IV

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Oct 4, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Terminated

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?Mayo Clinic

Study sponsor

Study overview

What this study is about

Purpose: Treatment
Study type: Interventional
Phase: Not applicable
Sponsor: Mayo Clinic
Interventions being studied: Procedure: Microwave ablation

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Disease setting

Metastatic or stage IV→

Treatment approach

Surgery→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Subject must be at least 18 years old.
Subject is able to understand the study procedures and provide informed consent.
Subject is willing and able to complete the entire study as specified in the protocol, including the follow-up visits.
Subject has lung lesion that is biopsy-proven cancer (of any type) or suspicious, with confirmation at the time of the procedure.
Lung lesion(s) are reachable/treatable per clinician opinion.
Subject can have other location of disease if it is controlled, or there are plans for control.
Subject has 1 or more lung nodules (not more than 10), that have a mean diameter \<3 cm on axial CT scan.
Life expectancy ≥6 months

Reasons someone may not be able to joinExclusion criteria

Subject is pregnant or breast feeding.
Subject has a significant clinical disease or condition, e.g. cardiovascular, respiratory, gastrointestinal, renal, hepatic, hematological, psychiatric or neurologic that would preclude enrollment, as determined by the primary investigator.
Subject has another location of disease that is not controlled, and there are no plans for control.
Subject has more than 10 lung nodules.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Mayo ClinicRochester, Minnesota
Mayo Clinic in RochesterRochester, Minnesota

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 4, 2023. Always confirm current availability with the study team.

View original record ↗